At the news
? BULLISHIMPACT 5/10 8-K filed Jun 26, 2026 at 17:30 ET
Outlook Therapeutics received a letter from Nasdaq on June 26, 2026, confirming that it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after its common stock closed at $1.00 or above for ten consecutive business days from June 11 to June 25, 2026. This resolves the delisting notice received on February 18, 2026, and the matter is now closed, removing a significant overhang on the stock.
- Nasdaq confirmed compliance with minimum bid price rule on June 26, 2026
- Stock closed at or above $1.00 for ten consecutive business days (June 11–25, 2026)
- Delisting matter is now closed
- Previously notified of non-compliance on February 18, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access